Skip to main content

Advertisement

SpringerLink
Log in

Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: the incremental value of nuclear medicine for patient management and care

  • Review Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

The 2005 Annual Congress of the European Association of Nuclear Medicine (EANM) took place in Istanbul on October 15–19, under the chairmanship of Professor Hatice Durak. The programme was of excellent quality and represented a further step towards the achievement of a standardized EANM congress structure. A large industrial exhibition demonstrated the latest technological innovations and developments within the field. The congress was a great success: there were more than 4,000 participants, and 1,670 abstracts were received. Of these, 1,399 were accepted for oral or poster presentations, with a rejection rate of 16.2%. The original investigations presented were related to different areas of nuclear medicine, and addressed particularly advances in instrumentation and data processing, progress in radiochemistry and pharmacy, novel diagnostics and therapeutics, and new insights in well-established areas of clinical application, such as oncology, cardiology, neurology, psychiatry, endocrinology, paediatrics, nephrology, and infection and inflammation. It is noteworthy that a number of studies presented at this congress focussed on the quantitative interpretation of the imaging data and on pragmatic endpoints, such as adverse outcomes, and identified when nuclear medicine procedures achieved clinical effectiveness for patient care and management. These and many other studies presented at the congress demonstrate once more the crucial role that nuclear medicine has to play in contemporary medicine. This highlights lecture is only a brief summary of the large amount of data presented and discussed, which can be found in much greater detail in the congress proceedings book, published as volume 32, supplement 1 of the Eur J Nucl Med Mol Imaging in September 2005.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16
Fig. 17
Fig. 18
Fig. 19
Fig. 20
Fig. 21
Fig. 22
Fig. 23

Similar content being viewed by others

References

  1. Beck R, Carlsen JM, Lebschi JA, Huisman MC, Reder S, Röper B, et al. Prognostic value of 18F-FAZA uptake for the efficiency of radiotherapy and hypoxia-directed chemotherapy in a murine tumor hypoxia model. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S37

    Google Scholar 

  2. van Dongen GAMS, Borjesson PKE, Roos JC, Jauw YWS, Boellaard R, Comans EFI, et al. Immuno-PET using zirconium-89-labeled chimeric MAb U36 for detection of lymph node metastases in head and neck cancer patients. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S79

    Article  PubMed  Google Scholar 

  3. Acampa W, Spinelli L, Sorrentino AR, Capacchione D, Paone G, Petretta M, et al. Comparison of prognostic value of negative dobutamine stress echocardiography vs single photon emission computed tomography after acute myocardial infarction. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S55

    Article  Google Scholar 

  4. Soler Peter M, Santana C, Ribera A, Faber T, Shaw L, Garcia E, et al. Prognostic value of left ventricular functional parameters by gated-FDG PET in ischaemic cardiomyopathy patients. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S178

    Google Scholar 

  5. Seneca N, Finnema S, Ichise M, Gulyas B, Wikstrom H, Innis R, et al. A comparison of amphetamine induced changes in agonist and antagonist radioligand binding potential on the dopamine D2 receptor in primate brain. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S82

    Google Scholar 

  6. Finnema SJ, Seneca N, Farde L, Gulyás B, Bang-Andersen B, Wikström HV, et al. Scatchard analysis of the D2 receptor agonist [11C]MNPA in the monkey brain using PET. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S82

    Google Scholar 

  7. Ferrari M, Cremonesi M, Rossi A, Militano D, Chinol M, Trifirò G, et al. Risks and optimization of radiation protection in radionuclide therapies with 90Y-conjugates. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S120

    Google Scholar 

  8. Slosman DO, Quinodoz M, Willi JP. Adequacy of PET imaging for monitoring treatment using SUV in clinical setting: proposal of standard indicators. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S36

    Google Scholar 

  9. Chan SC, Yen TC, Chang TC, Lin CY. Standardized uptake value of 2-[18F] fluoro-2-deoxy-D-glucose in predicting treatment outcome of primary nasopharyngeal carcinoma: a preliminary report. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S162

    Article  Google Scholar 

  10. Simonnet JA, Itti E, Haioun C, Rahmouni A, Mahloul M, Lepage E, et al. Predictive value of 18F-fluorodesoxyglucose positron emission tomography (FDG-PET) in aggressive non Hodgkin’s lymphoma with partial or unconfirmed response according to Cheson criteria. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S161

    Google Scholar 

  11. Zhao J, Gun YH, Lu S, Zuo CT, Lin XT. Detection of recurrent non-small cell lung cancer with integrated 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S105

    Article  PubMed  Google Scholar 

  12. Baum RP, Niesen A, Leonhardi J, Wortmann R, Müller D, Rösch F. Receptor PET/CT imaging of neuroendocrine tumors using the Ga-68 labelled, high affinity somatostatin analogue DOTA-1-Nal3-octreotide (DOTA-NOC): clinical results in 327 patients. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S54

    Google Scholar 

  13. Gutte G, Jacobsson D, Olofsson F, Ohlsson M, Jakobsen AL, Valind S, et al. Automated interpretation of PET/CT images in patients with lung cancer. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S143

    Article  Google Scholar 

  14. Bural GG, Shrikanthan S, Dhurairaj T, Urhan M, Srinivas S, Houseni M, et al. Lymph node necrosis in FDG-PET images in lymphoma and its clinical significance. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S145

    Google Scholar 

  15. Picchio M, Sironi S, Rabaiotti E, Moreni R, Surace M, Mangili G, et al. Influence of PET/CT on the clinical management of patients with suspected ovarian cancer recurrence. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S72

    Google Scholar 

  16. Schütz M, Wadsak W, Mitterhauser M, Rendl G, Paul M, Dudczak R, et al. Adrenocortical PET imaging with the novel tracer [18F]FETO: preliminary results in healthy volunteers. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S29

    Google Scholar 

  17. Strauss LG, Koczan D, Hoffend J, Haberkorn U, Pan L, Dimitrakopoulou-Strauss A. Evaluation of early effects of chemotherapy using a human colorectal cancer cell line. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S36

    Google Scholar 

  18. Laverman P, Frielink C, Morsche RH, Oyen WJG, Boerman OC, Drenth JPH. Early detection of cholangiocarcinoma with [18F]FDG in a rat model. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S96

    Google Scholar 

  19. Spanu A, Pirina P, Schillaci O, Solinas ME, Chessa F, Marongiu P, et al. The usefulness of 99mTc-tetrofosmin SPECT in the detection of primary lung cancer. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S140

    Article  Google Scholar 

  20. Hubalewska-Dydejczyk A, Fross K, Mikolajczak R, Pach D, Sowa-Staszczak A, Maecke HR, et al. 99mTc-EDDA/HYNIC-tate—an optimal radiotracer for detecting and staging of carcinoid tumors? Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S108

    Google Scholar 

  21. Solá M, Fuertes S, Fraile M, Rull M, Julián JF, Gubern JM, et al. Sentinel lymph node biopsy and immunohistochemical examination of bone marrow for the detection of isolated tumor cells in early stage breast cancer. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S137

    Google Scholar 

  22. Gomes CMF, Cleton-Jansen AM, Welling MM, van Paassen H, Hogendoorn PCV, Abrunhosa AJ, et al. Monitoring multidrug resistance (MDR) in osteosarcoma cell lines with 99mTc-sestamibi (MIBI) and 99mTc-tetrofosmin (Tfs). Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S99

    Google Scholar 

  23. Kartachova MS, Haas RLM, Verheij M, Valdés Olmos RA. Correlation between in vivo imaging of apoptosis by 99mTc-annexin V scintigraphy and tumor response in patients with malignant lymphoma. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S99

    Google Scholar 

  24. Kroon BK, Valdés Olmos RA, van Tinteren H, Nieweg OE, Horenblas S. Reproducibility of lymphoscintigraphy for lymphatic mapping in patients with penile carcinoma. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S48

    Article  Google Scholar 

  25. Maccauro M, Solima E, Villano C, Aliberti G, Bavusi S, Castellani M, et al. Sentinel lymph node detection following the hysteroscopic peritumoral injection of 99m Tc labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S49

    Article  Google Scholar 

  26. Armas F, Hernández M, Perera C, Travieso J, Isla C, Rodríguez J. Comparison between subareolar and peritumoral injection techniques with 99mTc-nanocolloid for sentinel node detection in breast cancer. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S118

    Google Scholar 

  27. Moretti A, Ridolfi R, Riccobon A, Galassi R, Giorgetti G, Stefanelli M, et al. Evaluation of in vivo migration of mature and immature radiolabelled dendritic cells and the different route of administration in cancer patients. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S136

    Article  Google Scholar 

  28. Picard C, Abouhammad P, Gerber B, Belge B, Vanoverschelde JL, Roelants V. Effect of temporal sampling on the evaluation of regional left ventricular function by ECG-gated perfusion SPECT in patients with severe ischemic cardiomyopathy in comparison with MRI. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S178

    Google Scholar 

  29. Bertagna F, Bosio G, Terzi A, Paghera B, Bettinsoli G, Cuccia C, et al. The contribution of gated-SPECT to predict left ventricular remodelling after acute myocardial infarction. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S45

    Google Scholar 

  30. Ferro A, Spinelli L, Acampa W, Pellegrino T, Capacchione D, De Corato G, et al. Direct comparison of interpretative reproducibility of stress myocardial perfusion imaging and stress echocardiography for the detection of inducible ischemia. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S38

    Article  Google Scholar 

  31. Ferro A, Acampa W, De Rimini ML, Cittanti C, Marranzano F, Spadafora M, et al. A prospective, multi-center trial to identify the prevalence of inducible ischemia in patients presenting with diabetes and suspected or known coronary artery disease: preliminary results. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S38

    Article  Google Scholar 

  32. Yapar AF, Aydin M, Reyhan M, Sukan A. Prognostic value of normal stress SPECT myocardial perfusion scintigraphy in diabetic patients with no known coronary artery disease. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S175

    Article  PubMed  Google Scholar 

  33. Magagnoli G, Pizzi C, Morelli R, Gavaruzzi G, Guidalotti P, Levorato M, et al. Prognosis of myocardial reversible perfusion in patients with angina and normal coronary angiograms. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S55

    Article  Google Scholar 

  34. Valle G, Stanislao M, Gimelli A, Perrone E, Martino G, De Rito V, et al. Gated single photon emission computed tomography (g-SPECT) in predicting cardiac resynchronization therapy (CRT) effectiveness. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S165

    Google Scholar 

  35. Pirich C, Graf S, Nikfardjam M, Khorsand A, Ofluoglu S, Nekolla SG, et al. Improvement in coronary vasoreactivity by folic acid is not related to homocysteine levels in subjects with coronary artery disease as assessed by N-13 ammonia PET. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S90

    Google Scholar 

  36. Flotats A, Simó M, Campreciós M, García J, Soler M, Rodríguez A, et al. Myocardial blood flow and glucose metabolism during the first six months of human heart transplantation. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S174

    Article  Google Scholar 

  37. Kampen WU, Zuhayra M, Gierthmühlen M, Sommer P, Faendrich F, Hedderich J, et al. Tc-99m labeled oligonucleotides against IL-2 mRNA for imaging of acute heart transplant rejection in a rat model. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S106

    Article  Google Scholar 

  38. Bural GG, Chamroonrat W, Torigian DA, El-Haddad G, Alavi A.Quantitative assesment of atherosclerotic burden, using SUVs and wall volumes of major arteries by combined FDG-PET and CY imaging. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S90

    Google Scholar 

  39. Sarda-Mantel L, Coutard M, Rouzet F, Vrigneaud JM, Vanderheyden JL, Merlet P, et al. 99mTc-annexin V imaging of thrombus activity in experimental rat aortic aneurysms. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S106

    Article  Google Scholar 

  40. Tamagnan GD, Haile CN, Brenner E, Koren AO, Bois F, Amici L, et al. [I-123] INER (YP-533), a high affinity SPECT imaging agent for the norepinephrine transporter. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S81

    Google Scholar 

  41. Catafau AM, Danus M, Bullich S, Abanades S, Barbanoj M, Penengo MM, et al. Ketanserin dose dependent displacement of the 5HT2A receptor SPECT ligand 123I-R91150. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S81

    Google Scholar 

  42. Poepperl G, Mehrkens JH, Koch W, Kreth FW, Gildehaus FJ, Tonn JC, et al. Correlation of FET uptake kinetics and tumor grading in patients with suspected recurrent gliomas. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S40

    Google Scholar 

  43. Henze M, Özdemir-Sahin N, Hipp P, Mier W, Eisenhut M, Debus J, et al. Comparison of the diagnostic accuracy of 18F-FDG PET, 123I-IMT- and 99mTc-MIBI SPECT in the evaluation of tumour progression in irradiated low grade astrocytomas with ROC-analysis. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S41

    Google Scholar 

  44. Buchmann I, Bense S, Schlindwein P, Buchholz H, Dieterich M, Bartenstein P. FDG-PET: neuronal correlates of visual self-motion perception. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S187

    Google Scholar 

  45. Varrone A, Pagani M, Salmaso D, Salvatore E, Sansone V, Nobili F, et al. Anterior cingulate hypoperfusion can differentiate progressive supranuclear palsy from Parkinson’s disease: voxel-based analysis and CBA-based PCA analysis of 99mTc-ECD SPECT data. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S64

    Google Scholar 

  46. Giovanella LC, Ceriani L, Keller F, Sacchi A. Low-risk differentiated thyroid carcinoma restaging: comparison of onT4-TG assay, neck ultrasound with TG assay on needle fluids and rhTSH-(TG assay+131J-WBS). Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S112

    Google Scholar 

  47. Voelker T, Sinha K, Steffen I, Misch D, Furth C, Hautzel H, et al. FDG-PET imaging for staging and follow-up of malignant pediatric sarcomas: preliminary results of a prospective multicenter study. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S75

    Article  Google Scholar 

  48. Zucchetta P, Biffanti R, Ruscazio M, Montisci R, Marzola M, Cecchin D, et al. Tc-MIBI adenosine G-SPECT and non-invasive coronary flow velocity reserve evaluation during follow-up of patients after cardio-pulmonary by-pass operated for congenital heart disease. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S86

    Google Scholar 

  49. Uchiyama M, Nishimoto H, Nozawa K, Oguma E, Kouno T. Cerebral blood flow SPET and response to acetazolamide challenge in premature craniosynostosis before and after surgery. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S75

    Article  Google Scholar 

  50. De Palma DD, Manzoni GA. Surgical risk for primary non-refluxing megaureter: are ultrasonographic and scintigraphic measurements prognostic values? Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S84

    Article  Google Scholar 

  51. Pifarre P, Irastorza I, Hill S, Roca I, Gordon I. V/Q scan in assessment of long-term parenteral nutrition. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S85

    Google Scholar 

  52. Prandini N, La Corte R, Lo Monaco A, Fabbri S, Costanzo A, Cittanti C, et al. Alveolar clearance of 99mTc-DTPA aerosol in the evaluation of lung involvement in 190 patients with systemic sclerosis. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S25

    Google Scholar 

  53. Sandler MP, Patton JA, Ben-Haim S, Coleman RE, Goldsmith SJ, Vidan E, et al. Wide beam reconstruction method for half SPECT scan time: a multi-center clinical evaluation. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S50

    Google Scholar 

  54. Bar-Sever Z, Steinmetz A, Shwartz SC. Enhancement of I-123 MIBG scans in children using the wide beam reconstruction method: preliminary evaluation. . Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S129

    Google Scholar 

  55. Boussion N, Hatt M, Lamare F, Turzo A, Bizais Y, Cheze Le Rest C, et al. A multiresolution approach in partial volume correction for emission tomography imaging. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S51

    Google Scholar 

  56. Mier W, Graham KAN, Krämer S, Hoffend J, Haberkorn U, Eisenhut M. Characterization of peptide-conjugated DOTA-oligomers. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S150

    Google Scholar 

  57. Wild D, Zhang H, Waser B, Schuhmacher J, Haberkorn U, Reubi JC, et al. Preclinical evaluation of DOTA-PEG4-bombesin (7-14), a very promising ligand for gastrin releasing peptide receptor targeting. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S77

    Article  Google Scholar 

  58. van Eerd JJEM, Broekema M, Harris T, Edwards SD, Oyen WJG, Corstens FHM, et al. Improved 99mTc-labeled LTB4 antagonist for imaging of infection and inflammation. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S35

    Google Scholar 

  59. Furumoto S, Okamura N, Ishikawa Y, Tashiro M, Kato M, Funaki Y, et al. [11C]BF227: a new 11C-labeled 2-ethenylbenzoxazole derivative for amyloid-β plaques imaging. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S268

    Google Scholar 

  60. Courbon F, Meynard K, Cassol E. MAGIC Polymer gel for internal targeted radiotherapy: preliminary dosimetry study with unsealed source of yttrium 90 (90-Y). Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S110

    Google Scholar 

  61. Pettinato C, Marengo M, Ciuffrida A, Civollani S, Pancaldi D, Laudicina L, et al. Self-absorbtion and 18F-FDG emission spectrum: effects on the shielding determination in a PET diagnostic room. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S68

    Google Scholar 

  62. Petrich T, Korkmaz Z, Knapp WH, Quintanilla-Martinez L, Pötter E. Experimental therapy by the alpha-particle emitter [At-211]-astatine of NIS expressing tumors in a mouse model. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S274

    Article  Google Scholar 

  63. Dadparvar S, Berkowitz A, Shrikanthan S, Schuster S, Alavi A. Comparison of In-111 labeled anti-CD20 antibody and FDG-PET imaging in low grade lymphomas prior to therapy: can we predict the response to Y-90 Zevalin therapy? Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S25

    Google Scholar 

  64. Alonso O, Chae I, Chung J, Gutierrez C, Kropp J, Onsel C, et al. Intravascular radiation therapy with liquid-filled 188Re balloon catheter: results of an International Atomic Energy Agency (IAEA) multicentre study. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S58

    Google Scholar 

  65. Nagy Z, Bokori G, Molnar F, Major L, Preda I, Szilvasi I. Intracoronary radionuclide therapy with liquid Re-188 to prevent restenosis. Biological factors. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S58

    Google Scholar 

  66. Durak H. Nuclear magic. Eur J Nucl Med Mol Imaging 2005;32(Suppl 1):S1–S3

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomorphological and Functional Sciences, University of Naples Federico II, Via S. Pansini 5, 80131, Napoli, Italy

    Alberto Cuocolo, Wanda Acampa, Andrea Varrone & Marco Salvatore

  2. Institute of Biostructures and Bioimages of the National Council of Research, Naples, Italy

    Alberto Cuocolo, Wanda Acampa, Andrea Varrone & Marco Salvatore

Authors
  1. Alberto Cuocolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wanda Acampa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Varrone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco Salvatore
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alberto Cuocolo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cuocolo, A., Acampa, W., Varrone, A. et al. Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: the incremental value of nuclear medicine for patient management and care. Eur J Nucl Med Mol Imaging 33, 360–381 (2006). https://doi.org/10.1007/s00259-006-1986-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-006-1986-1

Keywords

Search

Navigation